In our in-house MASLD-HCC mouse model, Fabp4 mRNA levels were significantly upregulated in MASLD-HCC, showing a gradient increase from steatosis to MASH and subsequently to HCC (Supplemental Figure 5). This evidence concerns the gene FABP4 and hepatocellular carcinoma.